Your browser doesn't support javascript.
loading
Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinib.
Banasavadi-Siddegowda, Yeshavanth Kumar; Namagiri, Sriya; Otani, Yoshihiro; Sur, Hannah; Rivas, Sarah; Bryant, Jean-Paul; Shellbourn, Allison; Rock, Mitchell; Chowdhury, Ashis; Lewis, Cole T; Shimizu, Toshihiko; Walbridge, Stuart; Kumarasamy, Sivarajan; Shah, Ashish H; Lee, Tae Jin; Maric, Dragan; Yan, Yuanqing; Yoo, Ji Young; Kumbar, Sangamesh G; Heiss, John D; Kaur, Balveen.
Affiliation
  • Banasavadi-Siddegowda YK; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Namagiri S; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Otani Y; Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Sur H; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Rivas S; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Bryant JP; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Shellbourn A; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Rock M; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Chowdhury A; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Lewis CT; Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Shimizu T; Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Walbridge S; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Kumarasamy S; Department of Biomedical Sciences Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.
  • Shah AH; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Lee TJ; Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Maric D; Flow and Imaging Cytometry Core Facility, NINDS, NIH, Bethesda, Maryland, USA.
  • Yan Y; Department of Surgery, Northwestern University, Chicago, Illinois, USA.
  • Yoo JY; Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Kumbar SG; Department of Orthopedic Surgery, University of Connecticut Health, Farmington, Connecticut, USA.
  • Heiss JD; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Kaur B; Department of Neurosurgery, University of Texas Health Science Center at Houston, Houston, Texas, USA.
Neurooncol Adv ; 4(1): vdac095, 2022.
Article in En | MEDLINE | ID: mdl-35875691
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Neurooncol Adv Year: 2022 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Neurooncol Adv Year: 2022 Document type: Article Affiliation country: United States